ライフサイエンスコーパス: seropositivity

1 utaneous vaccine with respect to the rate of seropositivity.

2 rology, likely due to the high prevalence of seropositivity.

3 magnetic resonance imaging, correlated with seropositivity.

4 e also evaluated factors associated with HEV seropositivity.

5 s, only older age remained predictive of HEV seropositivity.

6 ost significant risk factors associated with seropositivity.

7 continues to challenge the interpretation of seropositivity.

8 xposure is independently associated with HPV seropositivity.

9 for human papillomavirus (HPV)-16 and HPV-18 seropositivity.

10 nce of H1N1pdm09 vaccination or pre-pandemic seropositivity.

11 were strongly associated with post-pandemic seropositivity.

12 fer significantly according to recipient CMV seropositivity.

13 recent seroconversion, as well as sustained seropositivity.

14 als) as witnessed by their hepatitis C virus seropositivity.

15 n in Brazil, both tests detected 28%(n = 17) seropositivity.

16 tients had titers considered at baseline for seropositivity.

17 (1.9%) and other species exhibiting </=0.6% seropositivity.

18 al pathogen-specific antibody was considered seropositivity.

19 cantly associated with increased odds of HEV seropositivity.

20 fetal immunoglobulin M (IgM) umbilical cord seropositivity.

21 alarials were associated with HCV subtype 4k seropositivity.

22 ause survival in relation to HPV16 E6 and E7 seropositivity.

23 nd individual characteristics that relate to seropositivity.

24 ated with increasing age and cytomegalovirus seropositivity.

25 ere associated with 16/18 and 31/33/45/52/58 seropositivity.

26 and B-cell proportions by BK, JC, and HPyV9 seropositivity.

27 ause survival in relation to HPV16 E6 and E7 seropositivity.

28 HBV genotype C infection and maternal HBsAg seropositivity.

29 = 1.7 x 10(-8)), to be associated with HPV77 seropositivity.

30 memory was exhibited by 45% on the basis of seropositivity 1 week after vaccination and by 29% on th

31 usion criteria were as follows: (1) AQP4-IgG seropositivity, (2) myelitis attack and (3) MRI spinal c

32 The highest seropositivity (25/155) was observed within the age grou

33 %-70%] vs 98% [95% CI, 95%-100%]), and mumps seropositivity (59% [95% CI, 55%-64%] vs 97% [95% CI, 94

34 ine response occurred in 46% on the basis of seropositivity 8 weeks after vaccination and in 37% on t

35 assay (ELISA) thresholds for HPV16 and HPV18 seropositivity (8 and 7 ELISA units/mL, respectively, fo

36 CMV seropositivity accentuates further the accumulation of h

37 2.36) and inversely associated with SE36IgG1 seropositivity (adjusted OR: 0.37; 95% CI 0.21-0.64) and

38 BL was positively associated with HRP-IIIgG3 seropositivity (adjusted OR: 1.60; 95% CI 1.08-2.36) and

39 Seropositivity after 1 vaccine dose among children with

40 atitis A virus (anti-HAV) on the duration of seropositivity after hepatitis A vaccination during infa

41 H. pylori seropositivity also was inversely related to recent whee

42 Although the frequency of seropositivity among all participants through age 10 yea

43 Independent predictors of seropositivity among children with PHIV were receipt of

44 B. pseudomallei from a soil sample and high seropositivity among patient contacts suggest at least r

45 Seropositivity among recipients of 2 vaccine doses was >

46 ted an age-dependent association between HCV seropositivity and albuminuria (adjusted odds ratios and

47 al association between prevalent hepatitis C seropositivity and albuminuria and estimated GFR (eGFR),

48 a significantly higher risk of toxocariasis seropositivity and Anisakis simplex sensitization when c

49 prevalence of Toxocara spp. and Ascaris spp. seropositivity and associations with allergic diseases a

50 ort an inverse association between H. pylori seropositivity and asthma in children.

51 observed associations between genus-beta HPV seropositivity and BCC.

52 no association was observed between beta-HPV seropositivity and beta-HPV DNA-negative BCC.

53 ically significant association between HSV-2 seropositivity and CD4 count over time, but this differe

54 to examine the associations between pathogen seropositivity and cognitive impairment.

55 ion that showed association between anti-HEV seropositivity and functional epsilon3 and epsilon4 alle

56 Within the RA group, rheumatoid factor seropositivity and higher cumulative prednisone exposure

57 Seropositivity and higher IgG antibody levels against CM

58 Prevalence of paternal seropositivity and incidence of recent infection were ca

59 CMV seropositivity and lack of aggressive CMV prophylaxis co

60 ant recipient cytomegalovirus (CMV) antibody seropositivity and lack of aggressive prophylaxis agains

61 ificant association observed for hepatitis C seropositivity and low eGFR (<60 ml/min per 1.73 m(2); a

62 ns in p53 degradation, we evaluated HPV16 L1 seropositivity and MDM2 promoter variants to examine the

63 nce of a significant association between HIV seropositivity and OSSN.

64 ates the association between cytomegalovirus seropositivity and outcome in a large population of noni

65 Epidemiological surveys for MCPyV seropositivity and sequencing analyses of healthy human

66 was no significant association between HSV-2 seropositivity and the presence of fibroids (multivariab

67 ical information on the relationship between seropositivity and toxocariasis is limited.

68 No concordance between seropositivity and tumor DNA status was observed for HPV

69 ion less than 3 vertebral segments, AQP4-IgG seropositivity, and a final diagnosis of NMO or NMOSD.

70 C-reactive protein levels, rheumatoid factor seropositivity, and a lack of current treatment with dis

71 nfection with a detectable viral load, HBeAg seropositivity, and absence of HIV infection.

72 tuberculosis infection, hepatitis B and HIV seropositivity, and child and adult vaccination needs th

73 90 and were followed for analysis of safety, seropositivity, and neutralizing antibodies to DENV-1-4.

74 ptic neuritis, transverse myelitis, AQP4-IgG seropositivity, and recurrent myalgias with hyperCKemia.

75 hyroid peroxidase, and anti-transglutaminase seropositivity, and these autoantibodies did not correla

76 tenatal care coverage, and syphilis testing, seropositivity, and treatment in antenatal care.

77 Seropositivity (anti-HAV >/=20 mIU/mL) 30 years after th

78 ransplant recipients that betapapillomavirus seropositivity around transplantation significantly incr

79 es to assess risk factors for human MERS-CoV seropositivity at a farm complex in Qatar.

80 Determinants of seropositivity at age 4 were cord seropositivity (JCPyV,

81 robust variance to identify determinants of seropositivity at age 4.

82 iable DRB locus within the MHC region to HPV seropositivity at both the individual HPV type level and

83 gated whether neuromyelitis optica (NMO) IgG seropositivity at the initial presentation of longitudin

84 sed by occupational flour exposure and wheat seropositivity based on cross-reactivity to grass pollen

85 f 225 children was evaluated for CMV and EBV seropositivity before 2 years of age and for vaccination

86 Measuring seropositivity before vaccine introduction provides base

87 screening study of various NAbs showed 22.5% seropositivity belonging mostly to VGKC-complex antibodi

88 ere analyzed to examine risk factors for EBV seropositivity, both overall and by EBV type.

89 n assay and rubella seroprotection and mumps seropositivity by enzyme immunoassay.

90 h neurobehavioral disease is associated with seropositivity, causality is unproven.

91 Persistence of seropositivity conferred by hepatitis A vaccine administ

92 Seropositivity correlated directly with exposure risk in

93 plantation and that cytomegalovirus antibody seropositivity correlated with increased negative remode

94 Rates of seropositivity depended on the population, HPV type, and

95 Donor and recipient JC seropositivity did not predict BK viruria or viremia.

96 cancer risk factors with genus-specific HPV seropositivity differed by sex.

97 Seropositivity distinguishes autoimmune glial fibrillary

98 Recipient hepatitis C virus seropositivity, donor age, donor cause of death, and lif

99 Type-specific persistent seropositivity entailed elevated point estimates for SCC

100 Helicobacter pylori seropositivity, especially H. pylori cagA positivity, wa

101 were significantly associated with TES-ELISA seropositivity except vitreits (X(2) = 8.557, p = 0.003)

102 The primary end points were seropositivity for antibodies against measles and advers

103 nfluenza A(H7N9) infection in China found no seropositivity for antibodies specific for avian-origin

104 c groups, the number (weighted frequency) of seropositivity for antibody to HAV was 958 (24.9%), 802

105 In summary, seropositivity for certain HPV types was associated with

106 We aimed to examine whether seropositivity for CMV and the level of CMV immunoglobul

107 Seropositivity for CMV or EBV infection alters B cell re

108 T-cell subsets and immunoglobulin G seropositivity for CMV, EBV, herpes-simplex virus 1, and

109 In the discovery study, seropositivity for cytomegalovirus (CMV) in donors or re

110 for at least 1 of the 6 HY-Abs, and 3-month seropositivity for each HY-Ab was associated with a pers

111 Seropositivity for hepatitis C virus (HCV) predicts lowe

112 The prevalence ratio of seropositivity for HIV-positive females versus HIV-negat

113 Seropositivity for HPV types in genera alpha or beta inc

114 l associations were observed between BCC and seropositivity for HPV types in genus-alpha (odds ratio

115 Prevalence of seropositivity for human CMV increases with age.

116 Infant HBsAg seropositivity for more than 6 months was defined as chr

117 Seropositivity for pgp3 antibody varied from 1.4% (95% C

118 itis in patients with RA was associated with seropositivity for RF and the anti-CCP antibody, which w

119 ubset of patients studied for all endpoints, seropositivity for the E6 and E7 proteins was significan

120 (odds ratio, 12.3; 95% CI, 5.4 to 26.4), and seropositivity for the HPV-16 L1 capsid protein (odds ra

121 Seropositivity for tTGA resolved spontaneously, without

122 roup, antirotavirus immunoglobulin A and IgG seropositivity frequencies before vaccination (52.7% and

123 Two doses of the vaccine yielded seropositivity frequencies of 92.3%, 95.9%, and 99.0% (w

124 ore, patients with p16 staining and E6 or E7 seropositivity had favorable survival from oropharyngeal

125 EBV seropositivity has been connected to immunomodulatory ef

126 year among those with donor or recipient CMV seropositivity (hazard ratio 2.0: 95% confidence interva

127 mortality included recipient cytomegalovirus seropositivity (HR 1.40, 95% CI 1.13-1.74, p=0.0020), re

128 % CI 1.1 to 1.2; P = 0.004), and hepatitis C seropositivity (HR 2.8; 95% CI 1.1 to 7.0; P = 0.03) wer

129 HHV-8 seropositivity in children was independently associated

130 associated with genus-specific cutaneous HPV seropositivity in men and women.

131 Our findings suggest that baseline HPV seropositivity in men is not associated with reduced ris

132 e factors associated with genus-specific HPV seropositivity in men.

133 single-nucleotide polymorphisms and anti-HEV seropositivity in non-Hispanic blacks or between any sin

134 single-nucleotide polymorphisms and anti-HEV seropositivity in non-Hispanic whites or Mexican America

135 This high rate of Toxocara seropositivity in ocular patients should alert ophthalmo

136 CMV seropositivity in other conditions is associated with ar

137 ce of immunoblot-confirmed B burgdorferi IgG seropositivity in our uveitis patients is only slightly

138 over years, and prolonged waxing and waning seropositivity in some subjects, raises the possibility

139 Independent predictors of measles seropositivity in the 1967-1976 birth cohort were non-Hi

140 ncaster, we confirm previous observations of seropositivity in the majority of the population.

141 During 1999-2004, the rate of measles seropositivity in the population overall was 95.9% (95%

142 olor were associated with genus-specific HPV seropositivity in women.

143 Risk factors for HTLV-1 seropositivity included intravenous injections at hospit

144 strata, and analyzed factors associated with seropositivity, including age, gravidity, human immunode

145 Seropositivity increased slightly with age in only one d

146 respectively), whereas donor cytomegalovirus seropositivity increased the risk for late-onset IA (ie,

147 Seropositivity increased with increasing days of illness

148 antibody to HEV (anti-HEV) immunoglobulin G seropositivity indicating past or recent HEV infection a

149 The seropositivity induced by hepatitis A vaccine given to c

150 wave rose to 23%, either due to prepandemic seropositivity, infection or vaccination.

151 omarker of Epstein-Barr virus (anti-EBNA IgG seropositivity), infectious mononucleosis, and smoking s

152 immunodeficiency virus (HIV) and hepatitis B seropositivity, intestinal parasite test positivity, nee

153 JC virus (JCV) seropositivity is a risk factor for progressive multifoc

154 In the postvaccination era, anti-HBc seropositivity is a useful marker for OBI screening in H

155 eroprevalence rate of 36%, we find that HCMV seropositivity is associated with lower NK cell IFN-gamm

156 Seropositivity is associated with neurologic diseases an

157 Our findings suggest that PyV seropositivity is common in the United States and varies

158 ssociation noted between rs41270488 and HPV8 seropositivity is driven by two independent variants, na

159 High seropositivity is found in horses worldwide with approxi

160 tributable fraction of FGC for prevalent HCV seropositivity is high in women (79.8%).

161 at the risk of OSCC associated with HPV16 L1 seropositivity is modified by MDM2 promoter polymorphism

162 Adeno-associated virus type 2 (AAV2) seropositivity is negatively correlated with the develop

163 Seropositivity is now incorporated into new diagnostic c

164 HPV16 E6 seropositivity is relatively common before diagnosis of

165 We conclude that donor and/or recipient CMV seropositivity is still associated with an adverse progn

166 CMV seropositivity itself was not a risk factor for infectio

167 minants of seropositivity at age 4 were cord seropositivity (JCPyV, HPyV7, HPyV10, CMV), vaginal deli

168 born during 1967-1976 had the lowest measles seropositivity levels and represent populations that mig

169 population subgroups had evidence of measles seropositivity levels greater than the estimated thresho

170 galovirus (CMV)-specific cells, although CMV seropositivity modulated the distribution of lymphocyte

171 e agents (n = 8), and reported anti-JC virus seropositivity (n = 13).

172 h was significantly different from the 53.6% seropositivity observed in the overall MS study populati

173 icient 0.54; p<0.0001) and increased odds of seropositivity (odds ratio 1.59 [95% CI 1.1-2.3]) adjust

174 ntly associated with a CD4/CD8 ratio <1: CMV seropositivity (odds ratio [OR], 1.9 [95% confidence int

175 s, 19.5% (22 of 113) for blood samples, with seropositivity of 62.8% (71 of 113 samples) and with inc

176 inked immunosorbent assay (ELISA), we obtain seropositivity of 77%.

177 s with chronic urticaria more frequently had seropositivity of fasciolosis, Anisakis simplex sensitiz

178 ow specificity in areas where the background seropositivity of healthy people is high.

179 The negative prognostic effects of CMV seropositivity of the donor and/or the recipient (vs CMV

180 from a CMV-seronegative donor, cases of CMV seropositivity of the donor and/or the recipient showed

181 The authors estimated the effect of HSV-2 seropositivity on HIV RNA viral load and on CD4 count ov

182 inically meaningful effect of baseline HSV-2 seropositivity on the trajectories of HIV plasma viral l

183 s found no associations between maternal IgG seropositivity or antibody levels to herpes simplex viru

184 determine the association between cord serum seropositivity or detectable C-reactive protein and NICU

185 We found no associations between H. pylori seropositivity overall either by whole-cell ELISA test o

186 me sex partners and HIV infection) and HHV-8 seropositivity (P > .10).

187 a significantly greater decline in GFR than seropositivity (P < 0.01).

188 ic CD8(+) T-cell analysis (P = .05), and CMV seropositivity (P = .01) were associated with a higher p

189 FoxP3 PTLDs were associated with hepatitis C seropositivity (P = 0.03).

190 otypes of the two polymorphisms and HPV16 L1 seropositivity (P(int) = 0.060 for MDM2-rs2279744, P(int

191 flammatory markers, disease activity scores, seropositivity, physical disability, destructive changes

192 95% confidence interval, 1.30-23.62), as did seropositivity (positive likelihood ratio, 3.69 [1.67-8.

193 Seropositivity predictors were identified using multivar

194 CMV seropositivity (prevalence 59%) was associated with incr

195 was assigned to estimate the probability of seropositivity prior to antibody test results.

196 By using known anti-HBc seropositivity rate in children in our serosurveys, the

197 4-IgG positive, yielding an overall AQP4-IgG seropositivity rate of 89%.

198 nfection in fathers, relative to the average seropositivity rate of 9.8% for boys and men aged 12-49

199 BK polyomavirus is ubiquitous, with a seropositivity rate of over 75% in the adult population.

200 The observed perinatal HCV seropositivity rate was compared to the expected rate (5

201 Seropositivity rates 2 months after 2 doses of IPV were

202 Seropositivity rates and corresponding geometric mean ti

203 No differences existed in seropositivity rates by sex, age, age at receipt of the

204 Expected infant seropositivity rates reached 80% vs 55% following second

205 Although seropositivity rates remained similarly high (48 [94%] o

206 imary endpoint were GMCs and expected infant seropositivity rates, defined by birth anti-PT >30 enzym

207 Vaccine-induced seropositivity/reactivity, defined as reactive on 1 or m

208 Recurrent hyperCKemia accompanying AQP4-IgG seropositivity reflects targeting of skeletal muscle AQP

209 Neighborhood seropositivity results guided soil sampling to isolate B

210 efined by infant hepatitis B surface antigen seropositivity (risk ratio = 0.3, 95% confidence interva

211 nfidence interval 0.2-0.4) or infant HBV DNA seropositivity (risk ratio = 0.3, 95% confidence interva

212 netheless, the model indicated that anti-HAV seropositivity should persist for >/=30 years after vacc

213 HPV16 E6 seropositivity tended to increase in blood samples drawn

214 resulted in outer surface protein A-specific seropositivity that led to reductions of 23% and 76% in

215 those with both the TT genotype and HPV16 L1 seropositivity, the associated OR was 5.57 (95% CI, 2.93

216 childhood available for sampling maintained seropositivity through age 15-16 years; however, seropos

217 g/fall waves of the pandemic for evidence of seropositivity (titer >/=40) using the hemagglutination

218 A fourth QHPV dose increased seropositivity to >/=96% for all vaccine genotypes.

219 We used a multiplex panel to assess whether seropositivity to 15 Helicobacter pylori proteins was as

220 herefore investigated whether preexisting Ad seropositivity to 7 different Ad serotypes was associate

221 The age-adjusted prevalence of seropositivity to A(H1N1)pdm09 by year-end 2009 was 36.9

222 owever, 69%-74% of children maintained their seropositivity to AMA1 alleles and 42%-52% to MSP2 allel

223 Seropositivity to avian influenza (AI) via low-level ant

224 associations with gastric adenocarcinoma and seropositivity to different Helicobacter pylori antigens

225 These were IgG seropositivity to Epstein-Barr virus nuclear antigen (EB

226 Seropositivity to H. pylori proteins was associated with

227 Seropositivity to H. pylori was assessed using both mult

228 stitution (N145K/R) was sufficient to affect seropositivity to H3N2v viruses in some individuals.

229 of HIV-infected patients exhibit persistent seropositivity to HIV-1 and evidence of immune activatio

230 imens for HPV DNA or included assessments of seropositivity to HPV type 6, 11, 16, or 18 in men.

231 Baseline seropositivity to HPV types in genus beta species 2 was

232 Seropositivity to JC, MCV, and HPyV7 increased with age.

233 sorbent assay (ELISA) (HPV16 and HPV18 only) seropositivity to measures of HPV exposure, HPV DNA posi

234 Seropositivity to more herpesviruses was additively asso

235 the Step study, we observed that preexisting seropositivity to multiple Ad serotypes was not intrinsi

236 Seropositivity to PVs was associated with increasing age

237 onclusions, our cross-sectional study showed seropositivity to the NT5c1A antibody is associated with

238 in Japan and the United States, despite low seropositivity to TSST-1 in Japan.

239 ip between total infectious burden (additive seropositivity to various microbes) and cognition/AD.

240 immunosorbent assay units (EU)/mL to confer seropositivity until 3 months of age.

241 After 2 TDV doses, seropositivity was >95% in all 5 groups for DENV-1-3 and

242 Anticentromere antibody seropositivity was a significant, independent, protectiv

243 CMV seropositivity was also associated with impaired learnin

244 In particular, CMV seropositivity was an independent risk factor for cardio

245 Seropositivity was associated with a reduced cervical bu

246 However, HSV-2 seropositivity was associated with a shorter time to the

247 CMV seropositivity was associated with an increased risk of

248 HTLV-1 seropositivity was associated with female sex, older age

249 HTLV-2 seropositivity was associated with female sex, older age

250 However, CMV seropositivity was associated with higher levels of prev

251 Among older adults, HSV-1 seropositivity was associated with immediate memory impa

252 Seropositivity was associated with improved patient surv

253 Parental Toxocara spp. seropositivity was associated with increased offspring a

254 fspring than parents; however, Toxocara spp. seropositivity was associated with increased risk of all

255 Donor or recipient CMV seropositivity was associated with increased risk of CMV

256 Among children, HSV-1 seropositivity was associated with lower reading and spa

257 For HPV-18, although seropositivity was associated with lower risk of ASCUS+

258 seropositive but MCV-seronegative, and HPyV7 seropositivity was associated with prolonged glucocortic

259 Toxocara spp. seropositivity was associated with wheeze (2.97[1.45- 7.

260 and crypt depth measurements showed that HEV seropositivity was associated with worse enteropathy (P

261 HIV seropositivity was associated with worse outcomes overal

262 e screened by recombinant ELISA and MERS-CoV seropositivity was confirmed by recombinant immunofluore

263 Seropositivity was defined as an hSBA titer of 4 or high

264 Helicobacter pylori seropositivity was defined as those positive to >/= 4 an

265 C. trachomatis seropositivity was detected in 90% of the infected group

266 oped hepatobiliary cancer, the prevalence of seropositivity was higher: 100% for gallbladder cancer,

267 HPV-16 L1 seropositivity was highly associated with oropharyngeal

268 In multivariable analyses, HIV seropositivity was independently associated with mortali

269 H. pylori seropositivity was inversely associated with onset of as

270 HPV16 E6 seropositivity was less common for cancers of the cervix

271 positivity through age 15-16 years; however, seropositivity was less frequent among those starting va

272 Seropositivity was lower among males than among females

273 Seropositivity was maintained at month 12.

274 HPV16 E6 seropositivity was present in 29.2% of individuals (seve

275 HPV16 E6 seropositivity was present in prediagnostic samples for

276 HPV16 E6 seropositivity was present more than 10 years before dia

277 on Into Cancer and Nutrition study, HPV16 E6 seropositivity was present more than 10 years before oro

278 The prevalence of EBV seropositivity was significantly increased among females

279 Seropositivity was significantly lower in participants c

280 In multivariable analyses, HPV-16 seropositivity was significantly more common in WSM vs M

281 Measles seropositivity was uniformly high in the US population d

282 Seropositivity was very strongly associated with improve

283 Among asymptomatic contacts, seropositivity was weakly correlated with exposure level

284 tigate factors associated with cutaneous HPV seropositivity, we conducted a cross-sectional study of

285 V infection, and herpes simplex virus type 2 seropositivity were also predictive of incident HIV infe

286 -2.19] for OSCC risk, and GT/GG and HPV16 L1 seropositivity were associated with an OR of 2.81 (95% C

287 rus (CMV) and herpes simplex virus 1 (HSV-1) seropositivity were associated with cognitive impairment

288 Among middle-aged adults, HSV-1 and CMV seropositivity were associated with impaired coding spee

289 hic and lifestyle factors with cutaneous HPV seropositivity were estimated using odds ratios and 95%

290 Factors significantly associated with seropositivity were having skin wounds, sores, or ulcers

291 rted between 12 and 24 weeks of age, odds of seropositivity were increased 13.7 times (95% CI 3.1-60.

292 ariate analyses, factors associated with HEV seropositivity were increasing age (P-trend<0.001), birt

293 Independent risk factors for HCV subtype 4r seropositivity were intramuscular tuberculosis therapy,

294 JC and TSV seropositivity were more common among men than among wom

295 In addition, the associations with seropositivity were similar across smoking and/or drinki

296 edictors of rubella seroprotection and mumps seropositivity were similar.

297 onversion within 1 year (n=45), new anti-HCV seropositivity with clinical acute hepatitis (n=21), or

298 We also assessed odds of seropositivity with respect to age of ART initiation and

299 a susceptibility locus (rs41270488) for HPV8 seropositivity within the major histocompatibility compl

300 We hypothesized, therefore, that HCMV seropositivity would be associated with altered NK cell